Inform
Q3 earnings – Diamondback’s antivenom
This report is currently unavailable
Report summary
Diamondback Energy’s share price fell by 15% following its earnings calls. The company has long been one of Wall Street’s favorite E&Ps but this marks a rebase of expectations for the company. It also highlights that even the best performing management teams are not immune to operational challenges facing Permian players. There was plenty of negative messaging in the call, but what are the most pressing issues Diamondback faces?
Table of contents
- No table of contents specified
Tables and charts
No table or charts specified
What's included
This report contains:
Other reports you may be interested in
Insight
What would a second Trump presidency mean for US oil production?
There are levers that a second Trump administration would likely pull to positively affect production at the margin.
$1,350
Commodity Market Report
North America gas weekly update: Can we avoid triple digit injections?
Increased supply curtailments and LNG export utilizations are a powerful combination
$1,700
Insight
US week in brief: EOG's Utica combo competes with the best
The US week in brief highlights the need-to-know current events from US upstream. Stories are supplemented with proprietary WoodMac views.
$1,350
